- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed B-Cell Non-Hodgkin Lymphoma in Canada
Total 489 results
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)Merck Sharp & Dohme LLCRecruitingRelapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell LymphomaAustralia, Spain, United States, France, Hungary, New Zealand, Poland, Serbia, Canada, Romania
-
Hoffmann-La RocheAbbVieCompletedLymphoma, Non-HodgkinSpain, Hungary, United States, Canada, Australia, Austria, Czechia, France, Italy, Netherlands
-
Xencor, Inc.TerminatedDiffuse Large-cell B-cell LymphomaSpain, United States, France
-
Maisonneuve-Rosemont HospitalBayerUnknownNon-Hodgkins LymphomaCanada
-
GWT-TUD GmbHHoffmann-La RocheRecruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-cell LymphomaGermany, Spain, United Kingdom, Austria
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)United States, Spain, United Kingdom, Canada, Netherlands, Germany, France, Sweden, Israel, Switzerland, Belgium, Australia, Austria, Italy
-
Janssen Research & Development, LLCPharmacyclics LLC.TerminatedLymphoma, Non-HodgkinUnited States, France, Poland, United Kingdom, Germany, Taiwan, Spain, Bulgaria, Romania, Turkey, Ukraine, Canada, Korea, Republic of, Netherlands, Russian Federation, Belgium, Brazil, Hungary, Czechia, Sweden
-
Sunnybrook Health Sciences CentreMerck Sharp & Dohme LLC; ImmunoVaccine Technologies, Inc. (IMV Inc.)CompletedRecurrent | Adult Diffuse Large Cell Lymphoma | Adult Refractory Diffuse Large B-Cell LymphomaCanada
-
Canadian Cancer Trials GroupCelgeneCompletedDiffuse Large B-Cell Lymphoma | Peripheral T-Cell LymphomaCanada
-
Merck Sharp & Dohme LLCActive, not recruitingRelapsed or Refractory Diffuse Large B-Cell LymphomaUnited States, China, Poland, Israel, Canada, Chile, Czechia, Estonia, France, Greece, Italy, Korea, Republic of, Norway, Spain, Sweden, Thailand, Turkey
-
ADC Therapeutics S.A.RecruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaJapan, Belgium, France, Italy, Spain, United Kingdom, United States, Israel, Hungary, Brazil, Switzerland, Poland, Canada, Puerto Rico, Czechia, Netherlands, China, Mexico, Argentina, Chile, Turkey
-
Triphase Research and Development III Corp.CompletedLymphoma | Lymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Lymphoma, Marginal ZoneCanada, United States
-
PfizerUCB PharmaCompletedLymphoma, B-CellKorea, Republic of, Canada, Belgium, Singapore, United States, Hong Kong, Japan, United Kingdom, France
-
Novartis PharmaceuticalsActive, not recruitingDiffuse Large B-cell LymphomaSpain, Germany, Canada, Italy, Hong Kong, China, Japan, France, United States, Singapore
-
National Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Stage IV Adult Diffuse Large Cell Lymphoma | Adult Diffuse Large Cell LymphomaCanada
-
Gustave Roussy, Cancer Campus, Grand ParisChildren's Oncology GroupActive, not recruitingPrimary Mediastinal Large B Cell LymphomaFrance, Belgium, United Kingdom, Netherlands, Canada, Hungary, Italy, Poland, Spain
-
CelgeneCompletedDiffuse B-Cell LymphomaCanada, Spain, Belgium, United States
-
British Columbia Cancer AgencyNot yet recruitingMultiple Myeloma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell LymphomaCanada
-
Novartis PharmaceuticalsRecruitingDiffuse Large B-cell Lymphoma | B-cell Acute Lymphoblastic LeukemiaJapan, Canada
-
Epizyme, Inc.CompletedB-cell Lymphomas (Phase 1) | Advanced Solid Tumors (Phase 1) | Diffuse Large B-cell Lymphoma (Phase 2) | Follicular Lymphoma (Phase 2) | Transformed Follicular Lymphoma | Primary Mediastinal Large B-Cell LymphomaAustralia, Canada, France, Germany, Italy, Poland, Taiwan, Ukraine, United Kingdom, United States
-
The Hospital for Sick ChildrenCompleted
-
Allogene TherapeuticsRecruitingRelapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic LymphomaUnited States, Spain, Canada, Australia, Italy
-
CelgeneTerminatedLymphoma, Large B-Cell, DiffuseUnited States, France, Canada, Italy
-
Canadian Cancer Trials GroupAbbVie; Roche Pharma AG; Incyte CorporationRecruiting
-
BayerCompletedDiffuse, Large B-Cell, LymphomaBelgium, France, Canada, Korea, Republic of, Australia, Germany, United Kingdom, Italy, Denmark, Singapore
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Lymphoplasmacytic... and other conditionsUnited States, Canada
-
Astellas Pharma IncTerminatedLymphoma, Large-Cell, Diffuse | Lymphoma, B-Cell RefractoryFrance, Spain, United States, Canada
-
Hoffmann-La RocheGenentech, Inc.TerminatedB-cell LymphomaItaly, China, United States, New Zealand, Canada, Australia, Austria, France, Spain, United Kingdom, Brazil, Colombia, Russian Federation, Thailand, Germany, Panama, Peru, Korea, Republic of, Hong Kong, Sweden, Argentina, Ecuador, P... and more
-
Calithera Biosciences, IncTerminatedDiffuse Large B-cell LymphomaSpain, United States, Italy, Canada, France, United Kingdom
-
AmgenCompletedHigh-risk Diffuse Large B-Cell LymphomaUnited States, Canada, Germany, Spain, France, United Kingdom
-
Calithera Biosciences, IncCompletedLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Large B-cell, DiffuseUnited States, Canada, Germany
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States, Japan, Australia, Italy, Canada, Germany, Norway, Netherlands, France, Austria
-
AmgenTerminatedMantle Cell Lymphoma (MCL) | Follicular Lymphoma (FL) | Diffuse Large B-cell Lymphoma(DLBCL)United States, Canada, Germany, Belgium
-
Novartis PharmaceuticalsAvailableAcute Lymphoblastic Leukemia (ALL) | Diffuse Large B-cell Lymphoma (DLBCL)United States, Canada, Australia
-
Celgene CorporationTerminatedDiffuse Large B-cell LymphomaUnited States, Canada, Australia
-
BeiGeneRecruitingFollicular Lymphoma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | B-cell MalignancyUnited States, Spain, Italy, Australia, France, Korea, Republic of, Canada, Georgia, Sweden, Germany, Moldova, Republic of
-
Grupo Español de Linfomas y Transplante Autólogo...CompletedDiffuse Large B-cell LymphomaSpain
-
AbbVieRecruitingFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Chronic Lymphocytic LeukemiaUnited States, Australia, Canada, Israel
-
Merck Sharp & Dohme LLCRecruitingDiffuse Large B-Cell Lymphoma | DLBCLPoland, United States, France, Israel, Italy, Turkey, Canada, Korea, Republic of, United Kingdom, Thailand, China
-
The Hospital for Sick ChildrenTerminatedAcute Myeloid Leukemia (AML) | Acute Lymphocytic Leukemia in Relapse | Burkitt's Lymphoma Stage III | Burkitt's Lymphoma Stage IV | Type 3 Diffuse Large B-Cell LymphomaCanada, United States
-
MorphoSys AGICON Clinical ResearchActive, not recruitingDiffuse Large B-cell LymphomaUnited States, Hungary, Italy, Poland, Spain, Czechia, Germany, Australia, Austria, Canada, Croatia, Finland, France, Israel, Korea, Republic of, New Zealand, Portugal, Romania, Serbia, Singapore, Taiwan, Turkey, United Kingdom
-
MorphoSys AGCompletedDiffuse Large B Cell LymphomaFrance, Italy, Spain, United States, Austria, Australia, Germany, Korea, Republic of, Canada, Denmark, Taiwan, United Kingdom
-
Seagen Inc.Active, not recruitingDiffuse Large B-cell LymphomaUnited States, France, Australia, Czechia, Italy, Spain, Canada, Belgium, Korea, Republic of, United Kingdom, Poland, Denmark, Germany, Netherlands, Switzerland, Taiwan
-
Hoffmann-La RocheCompletedLymphomaUnited States, Italy, Korea, Republic of, Australia, Canada, Czechia, Spain, United Kingdom, France, Germany, Hungary, Turkey, Netherlands
-
GenmabAbbVieActive, not recruitingDiffuse Large B-cell LymphomaKorea, Republic of, Spain, Taiwan, Belgium, France, Israel, United Kingdom, China, United States, Netherlands, Japan, Sweden, Turkey, Australia, Singapore, Germany, Denmark, Poland, Italy, Hungary, Austria, Russian Federation, Norway, Canad... and more
-
Karyopharm Therapeutics IncRecruitingDiffuse Large B-cell LymphomaUnited Kingdom, United States, Australia, Austria, Belgium, Bulgaria, Canada, France, Germany, Greece, Hungary, India, Israel, Italy, Netherlands, New Zealand, Poland, Serbia, Spain
-
GenmabAbbVieRecruitingNon-hodgkin LymphomaUnited States, Australia, France, Israel, Korea, Republic of, Spain, Taiwan, Japan, Italy, Belgium, Germany, Canada, Turkey, Czechia
-
Incyte CorporationCompletedLymphomaUnited States, Spain, Korea, Republic of, Belgium, Australia, Czechia, Poland, Canada, France, Italy, United Kingdom
-
MedImmune LLCCompletedDiffuse Large B-Cell LymphomaUnited States, France, Spain, Canada, Turkey, Israel, Germany, Russian Federation, Czechia, Hungary, Poland
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States, Canada